Literature DB >> 18038999

Effect of polymer amphiphilicity on loading of a therapeutic enzyme into protective filamentous and spherical polymer nanocarriers.

Eric A Simone1, Thomas D Dziubla, Francheska Colon-Gonzalez, Dennis E Discher, Vladimir R Muzykantov.   

Abstract

Rapid clearance and proteolysis limit delivery and efficacy of protein therapeutics. Loading into biodegradable polymer nanocarriers (PNC) might protect proteins, extending therapeutic duration, but loading can be complicated by protein unfolding and inactivation. We encapsulated active enzymes into methoxy-poly(ethylene glycol- block-lactic acid) (mPEG-PLA) PNC with a freeze-thaw double emulsion ( J. Controlled Release 2005, 102 (2), 427-439). On the basis of concepts of amphiphile self-assembly, we hypothesized that the copolymer block ratio that controls spontaneous curvature would influence PNC morphology and loading. We examined PNC yield, shape, stability, loading, activity, and protease resistance of the antioxidant enzyme, catalase. PNC transitioned from spherical to filamentous shapes with increasing hydrophobic polymer fraction, consistent with trends for self-assembly of lower MW amphiphiles. Importantly, one diblock copolymer formed filamentous particles loaded with significant levels of protease-resistant enzyme, demonstrating for the first time encapsulation of an active therapeutic enzyme into filamentous carriers. PNC morphology also greatly influenced its degradation, offering a new means of controlled delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038999     DOI: 10.1021/bm700888h

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  20 in total

Review 1.  Nanocarriers for vascular delivery of anti-inflammatory agents.

Authors:  Melissa D Howard; Elizabeth D Hood; Blaine Zern; Vladimir V Shuvaev; Tilo Grosser; Vladimir R Muzykantov
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

Review 2.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

3.  Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease.

Authors:  Anna M Brynskikh; Yuling Zhao; R Lee Mosley; Shu Li; Michael D Boska; Natalia L Klyachko; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2010-04       Impact factor: 5.307

4.  Loading PEG-catalase into filamentous and spherical polymer nanocarriers.

Authors:  Eric A Simone; Thomas D Dziubla; Evguenia Arguiri; Vanessa Vardon; Vladimir V Shuvaev; Melpo Christofidou-Solomidou; Vladimir R Muzykantov
Journal:  Pharm Res       Date:  2008-10-28       Impact factor: 4.200

5.  Synthesis and characterization of polymer nanocarriers for the targeted delivery of therapeutic enzymes.

Authors:  Eric Simone; Thomas Dziubla; Vladimir Shuvaev; Vladimir R Muzykantov
Journal:  Methods Mol Biol       Date:  2010

Review 6.  Targeted delivery of therapeutics to endothelium.

Authors:  Eric Simone; Bi-Sen Ding; Vladimir Muzykantov
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

Review 7.  Polymeric carriers: role of geometry in drug delivery.

Authors:  Eric A Simone; Thomas D Dziubla; Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2008-12       Impact factor: 6.648

8.  Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase.

Authors:  Eric A Simone; Thomas D Dziubla; Dennis E Discher; Vladimir R Muzykantov
Journal:  Biomacromolecules       Date:  2009-06-08       Impact factor: 6.988

Review 9.  Non-affinity factors modulating vascular targeting of nano- and microcarriers.

Authors:  Jacob W Myerson; Aaron C Anselmo; Yaling Liu; Samir Mitragotri; David M Eckmann; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2015-10-24       Impact factor: 15.470

Review 10.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.